APA (7th ed.) Citation

P, M., C, B., V, C., F, P., A, L., A, V., . . . G, A. (2011). Cardiovascular risk factors in patients on long-term treatment with nevirapine- or efavirenz-based regimens. The Journal of antimicrobial chemotherapy, 66(4), 896. https://doi.org/10.1093/jac/dkq507

Chicago Style (17th ed.) Citation

P, Maggi, et al. "Cardiovascular Risk Factors in Patients on Long-term Treatment with Nevirapine- or Efavirenz-based Regimens." The Journal of Antimicrobial Chemotherapy 66, no. 4 (2011): 896. https://doi.org/10.1093/jac/dkq507.

MLA (9th ed.) Citation

P, Maggi, et al. "Cardiovascular Risk Factors in Patients on Long-term Treatment with Nevirapine- or Efavirenz-based Regimens." The Journal of Antimicrobial Chemotherapy, vol. 66, no. 4, 2011, p. 896, https://doi.org/10.1093/jac/dkq507.